Takuro Nagoya

Inhibition of sodium glucose cotransporter 2 (<scp>SGLT</scp>2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (<scp>NASH</scp>)

Ryo Goto, Kenya Kamimura, Yoko Shinagawa‐Kobayashi et al. · FEBS Open Bio · 2019 · 20 citations · Full text

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver

Masayoshi Ko, Kenya Kamimura, Takashi Owaki et al. · Disease Models & Mechanisms · 2021 · 20 citations · Full text

Fatty Liver Disease, Gastrointestinal Peptide Hormone, Inflammation +22

Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma

Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abé et al. · Cancers · 2020 · 18 citations · Full text

Hepatology, Hcc Cell Lines, Oncogenic Agent +11

Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

Takashi Owaki, Kenya Kamimura, Masayoshi Ko et al. · Disease Models & Mechanisms · 2022 · 15 citations · Full text

Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression

Norihiro Sakai, Kenya Kamimura, Hirotaka Miyamoto et al. · Journal of Gastroenterology · 2022 · 14 citations

Ctgf Pathway, Fibrosis, Liver Fibrosis +9